SOD1 and amyotrophic lateral sclerosis: Unlike fNPCs alone, this combined cell and growth factor ex vivo therapy could protect spinal motor neurons in the SOD1 ALS rat, as well as dopamine neurons in a Parkinsonian rat model (Behrstock et al., 2006; Klein et al., 2005; Suzuki et al., 2007).